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Abstract
Background/Objectives: White matter hyperintensities (WMH) in magnetic resonance imaging (MRI) scans of the brain, and
orthostatic hypotension (OH) are both common in older people. We tested the hypothesis that OH is associated with WMH.
Design: Cross-sectional study.
Setting: Secondary care outpatient clinics in geriatric medicine and old age psychiatry in western Norway.
Participants: 160 older patients with mild dementia, diagnosed according to standardised criteria.
Measurements: OH was diagnosed according to the consensus definition, measuring blood pressure (BP) in the supine
position and within 3 minutes in the standing position. MRI scans were performed according to a common protocol at three
centres, and the volumes of WMH were quantified using an automated method (n = 82), followed by manual editing. WMH
were also quantified using the visual Scheltens scale (n = 139). Multiple logistic regression analyses were applied, with
highest vs. lowest WMH quartile as response.
Results: There were no significant correlations between WMH volumes and systolic or diastolic orthostatic BP drops, and no
significant correlations between Scheltens scores of WMH and systolic or diastolic BP drops. In the multivariate analyses,
only APOEe4 status remained a significant predictor for WMH using the automated method (p = 0.037, OR 0.075 (0.007–
0.851)), whereas only age remained a significant predictor for WMH scores (p = 0.019, OR 1.119 (1.018–1.230)).
Conclusion: We found no association between OH and WMH load in a sample of older patients with mild dementia.
Citation: Soennesyn H, Nilsen DW, Oppedal K, Greve OJ, Beyer MK, et al. (2012) Relationship between Orthostatic Hypotension and White Matter Hyperintensity
Load in Older Patients with Mild Dementia. PLoS ONE 7(12): e52196. doi:10.1371/journal.pone.0052196
Editor: Antony Bayer, Cardiff University, United Kingdom
Received August 31, 2012; Accepted November 9, 2012; Published December 19, 2012
Copyright:  2012 Soennesyn et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported financially by Grant 911694 from the Western Norway Regional Health Authority (http://www.helse-vest.no/fagfolk/
forskning/det-regionale-samarbeidsorganet/Sider/side.aspx), and by two grants from MoodNet Research Group (http://www.helse-bergen.no/moodnet) (grant
numbers not available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hogne.soennesyn@sus.no
Introduction
White matter hyperintensities (WMH) are commonly found in
cerebral T2-weighted magnetic resonance imaging (MRI) scans in
older people [1,2]. WMH seem to have a common distribution
regardless of underlying diagnosis [3–4], with a preference for
areas of lower relative perfusion. They have been associated with
depression [5] and dementia [6]. WMH predict functional decline
in voiding, mobility and cognition, and depression [7–9].
WMH have been associated, although only modestly [10], with
classic cardiovascular risk factors [2,11] including hypertension
[12] and APOEe4 [13], and are considered a marker of
cerebrovascular disease. Alternatively, WMH may, at least in
Alzheimer’s disease (AD), primarily be associated with neurode-
generative disease [14]. However, some studies [15–19] suggest
that hypotension, including orthostatic hypotension, plays a role in
the development of WMH.
Orthostatic hypotension (OH) [20] is common in older people
[21], and particularly in older people with dementia [22,23]. OH
is associated with falls [24], coronary heart disease and increased
mortality [25].
Furthermore, one older study using CT scans found seated
systolic blood pressure (BP) below 130 to be predictive of having
white matter low attenuation (equivalent to WMH in MRI) of the
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brain [26], suggesting that the absolute BP level might be of
importance.
In this study we wanted to explore the association between OH
and WMH in older people with mild dementia. We hypothesized
that systolic and/or diastolic BP drop at baseline are positively
correlated with total WMH volumes and Scheltens deep WMH
scores, and that having OH, or standing systolic BP at or below
110 mm Hg at baseline is independently associated with having
more severe WMH on imaging. Since OH appears to be
particularly common in Lewy body dementias [27], we tested this
association separately.
Methods
Subjects
Consecutive referrals to dementia clinics in the counties of
Rogaland and Hordaland in western Norway from March 2005 to
March 2007 were screened, and patients with a first time diagnosis
of mild dementia, i.e. a minimum Mini-Mental State Examination
(MMSE) score of 20 were included. From April 2007 we
selectively recruited patients with dementia with Lewy bodies
(DLB) and Parkinson’s disease with dementia (PDD) fulfilling the
aforementioned criteria of mild dementia. A total of 246 patients
have completed baseline assessments, the last of whom was
included in May 2011. In the current study, we included those
who had both OH measurements and available MRI scans with
adequate scan quality.
Ethics Statement
The study was approved by the Regional Committee for
Medical Research Ethics, Western Norway and the Norwegian
authorities for collection of medical data. The subjects provided
written consent to participate after the study procedures had been
explained in detail to them and a caregiver, usually the spouse or
offspring.
Dementia Diagnosis
The diagnoses for AD, DLB, PDD and vascular dementia
(VaD) were made according to consensus criteria [28–31], and for
frontotemporal dementia (FTD) and alcoholic dementia according
to the Lund-Manchester criteria [32] and the DSM-IV criteria,
respectively. DLB and PDD were combined into one group (Lewy
body dementia, LBD), because these conditions have several
clinical and biological similarities [29,33].
The diagnostic procedures and comprehensive standardised
assessment have been described elsewhere [34]. Patients with
acute delirium or terminal illness, as well as those recently
diagnosed with a major somatic illness, previous bipolar disorder
or psychotic disorder were excluded.
Blood Pressure Measurements
Blood pressures were measured at baseline only, using an
analogue sphygmomanometer. The protocol did not require
a period of rest prior to the BP measurements. In the majority
of patients, BP was measured once with the subject in the supine
position, and then once (all patients) within 3 minutes after
standing up. In some patients, the non-standing BP measurements
were made in the sitting position (22/80 in the volumetry group,
and 60/134 in the semi-quantitative group). For n= 9 patients the
non-standing position is unknown.
Orthostatic hypotension (OH) was defined according to the
consensus as a reduction of systolic BP of at least 20 mm Hg or
diastolic BP of at least 10 mm Hg within 3 minutes of standing
[20]. The diagnosis of OH was based solely on the baseline BP
measurements.
By contrast, a diagnosis of hypertension was based on the
medical history and the medical records only, and not on the
baseline BP measurements.
The assessments took place during normal office hours (i.e.
8 a.m. to 4 p.m.).
APOE
Apolipoprotein E (APOE) genotypes were determined in
a subgroup. First, genomic DNA was extracted from 200 ml
EDTA-blood using the QIAamp 96 DNA Blood Kit (Qiagen,
Hilden, Germany). For detection of the APOE e2, e3 and e4
genotypes, which are determined by the combination of two SNP’s
(rs7412 and rs429358), we employed the LightCycler APOE
Mutation Detection Kit (Roche Diagnostics, Mannheim, Ger-
many), using the assay according to the instructions of the
manufacturer.
Assessment of Physical Comorbidity
We employed the ‘‘Cumulative Illness Rating Scale’’ (CIRS) for
assessment of physical comorbidity. This instrument measures the
chronic medical illness burden, while also taking into account the
severity of chronic diseases. Scoring was done by an experienced
geriatrician, in accordance with guidelines [35].
MRI
Patients were scanned at three different sites; Stavanger
University Hospital, Haugesund Hospital, and Haraldsplass
Deaconess Hospital (Bergen). 1.5 T scanners were used in all
three centres (Philips Intera in Stavanger and Haugesund, and in
Bergen a 1.5T GE Signa Excite scanner). In each centre, MRI was
done on the same scanner during the entire study period, and
a common study imaging protocol was used. For technical details,
see Soennesyn et al. [9]. A phantom study, using the same three
scanners, of three human volunteers was done for the DemWest
study and has recently been published [36]. This was done to
assess the variability between scanners and also to assess intra-
scanner variability. Cronbach’s alpha between the three MRI
scanners, as well as between two points in time, all exceeded 0.95,
indicating excellent reliabilities.
The MRI scans were performed within a median interval of 2
months (interquartile range 1–4 months) from the baseline clinical
examination.
Volumetric assessment of WMH. Image analysis was
performed according to a method developed and previously
published by Firbank et al. [4] and modified as previously
described [9]. Briefly, this method requires sets of 3DT1 weighted
scans and FLAIR images from each patient. Non-brain regions
were removed from the T1 image, and the WMH were segmented
on a slice-by-slice basis from the FLAIR image, using a threshold
determined from the histogram of pixel intensities for each image
slice. An MNI atlas image registered to the FLAIR image was used
to calculate the WMH volumes in different regions of the brain.
Because of the variability in image quality from the different
centres participating in this study, we found it difficult to
empirically choose a single threshold level that gave us a perfect
segmentation result in each subject. Therefore, a threshold level of
1.2 was chosen, by which the lesion load was overestimated. Later,
manual correction was performed by removing excess pixels using
FSLView (http://www.fmrib.ox.ac.uk/fsl/index.html).
A specialist in internal medicine and geriatrics (HS) performed
the manual editing, blind to clinical data, after training by
a consultant neuroradiologist (MKB). They both edited the same
OH and WMH in Mild Dementia
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10 datasets twice; once in the beginning, to secure good inter-rater
reliability, and a second time at the end of the editing process, to
secure that similar reliability still persisted and to evaluate intra-
rater reliability. The intraclass correlation coefficient (ICC) was
calculated to be 0.998 for inter-rater reliability and 0.964 for intra-
rater reliability. The manually edited scans were then used in the
further analyses of volumes of total and regional WMH. In order
to compensate for interindividual differences in total brain
volumes, we calculated the ratios of volumes of WMH to total
brain volumes, using these in the statistical analyses. In the present
study, we used only the ratios of total WMH volumes, which have
been shown to be highly correlated with regional WMH volumes
[37].
Visual assessment of WMH. MRI’s were also rated visually,
using the Scheltens scale [38], by an experienced rater (OJG),
blind to clinical data. According to the Scheltens scale, white
matter changes (WMC) are subdivided into periventricular WMC
and deep WMC, and deep WMC are further subdivided into deep
WMH (DWMH), basal ganglia WMH (BGH) and infratentorial
hyperintensities (IT) [39]. In the statistical analyses, we used only
the DWMH scores, because these have been associated with
(orthostatic) BP drop in previous studies [15,17]. Inter-rater
reliability with another experienced rater (MKB) was evaluated,
based on 12 scans, finding an ICC of 0.923.
Statistical Analyses
A total of 82 patients had MRI scans that could be analysed
volumetrically (volumetry group), and 139 had scans that could be
rated semi-quantitatively (the semi-quantitative group) according
to the Scheltens scale. The scans of 61 patients were analysed with
both methods, yielding a correlation coefficient (Spearman’s rho)
of 0.791 (p,0.001) between the scores of the two methods. Mann-
Whitney U-test, Chi-square, Spearman rank order or Fisher’s
exact test were used as appropriate. None of the continuous
variables had a normal distribution, according to the Kolmogorov-
Smirnov test.
Potential predictor variables having p-values ,0.25 in bivariate
logistic regression analyses were included in stepwise multiple
logistic regression analyses, with the response variable defined as
being in the highest quartile of total WMH volume ratios or
Scheltens deep WMH (DWMH) scores vs. the lowest quartile,
respectively.
P-values ,0.05 (two-tailed) were considered statistically signif-
icant.
All statistical tests were performed using PASW Statistics 18,
release 18.0.1.
Results
When comparing the baseline characteristics of patients un-
dergoing WMH volume analysis with those who were not included
in the study, the only significant difference was a higher proportion
with Alzheimer’s disease among the participants (volumetry group:
Pearson Chi square 14.558, df 1, p,0.001, semi-quantitative
group: Pearson Chi square 8.162, df 1, p= 0.006 (Table 1)).
In the volumetry group, the only significant difference with
respect to relevant clinical characteristics between patients in the
highest and lowest WMH quartiles was a lower proportion in the
former group with at least one APOEe4 allele (Table 2).
In the semi-quantitative group, patients in the highest DWMH
score quartile were significantly older than those in the lowest
quartile, and the proportion of patients with a previous stroke was
significantly higher in the highest quartile. Otherwise, there were
no significant differences between those belonging to the highest
and lowest DWMH score quartiles.
We did not find any significant association between a history of
hypertension and having OH at baseline (Pearson Chi Square
0.224, df 1, p = 0.636).
Associations between WMH and OH
There was no significant correlation between WMH volume
ratios and the systolic orthostatic BP drops (Spearman’s rho 0.022,
p = 0.848), but a trend with diastolic orthostatic BP drops was
demonstrated (Spearman’s rho 20.213, p = 0.066). Similarly, we
found no significant correlations between DWMH scores and
systolic or diastolic orthostatic BP drops (Spearman’s rho 0.037,
p = 0.700 and Spearman’s rho 20.122, p = 0.202, respectively).
We performed bivariate logistic regression analyses with the
variables in Table 2 as predictors, and being in the highest WMH
quartile vs. the lowest quartile as response variable. In the
volumetry group, age, hypertension, coronary heart disease and
APOEe4 status had p-values ,0.25. As to the semi-quantitative
group, age, hypertension, APOEe4 status and previous stroke had
p-values ,0.25. None of the p-values for the BP variables
approached this level, except diastolic BP drop vs. DWMH score
(p = 0.297). The aforementioned variables having p-values ,0.25
were entered into stepwise multiple logistic regression analyses.
In the final model, only APOEe4 status remained a significant
predictor of the volumes of WMH (Table 3). The model
performed well (Omnibus test of model coefficients p,0.05), and
the model fit was good (Generalised linear models, Pearson Chi
Square p= 0.179). Only age remained a significant predictor of
DWMH scores (Table 4). The model performed well (Omnibus
test of model coefficients p= 0.010), and the model fit was good
(Hosmer and Lemeshow test p = 0.492).
We also performed multiple logistic regression analyses (stepwise
and forced entry) controlling for scanning site and including
variables known from previous studies to be associated with WMH
(age, hypertension, diabetes mellitus), in addition to OH or systolic
or diastolic BP drops. In these analyses, both with respect to the
volumetry group and the semi-quantitative group, only age
remained a significant predictor of WMH load (data not shown).
However, in some of the models the predictor ‘‘MRI centre’’
achieved borderline significance (p = 0.048–0.050).
When analysing the patients with DLB/PDD separately, we
found no significant correlations between Scheltens DWMH
scores and systolic or diastolic BP drops. Similarly, there were no
significant differences between those in the highest and lowest
Scheltens DWMH score quartiles with respect to the other
variables in Table 2 (data not shown). In bivariate logistic
regression analyses, diastolic BP drop, age and APOEe4 status
achieved the lowest p-values (0.124, 0.117 and 0.094, respectively).
Due to the rather small subsample, in combination with missing
values for the relevant variables, it was not statistically feasible to
perform multiple logistic regression analyses using these variables.
Discussion
The main finding of our study is that in this sample of older
people with mild dementia, WMH were not associated with OH
or low standing systolic BP. Only APOEe4 status (volumetry) and
age (volumetry and semi-quantitative analysis) were independently
associated with WMH volumes.
Thus, our hypothesis that WMH in mild dementia are
associated with OH was not supported. This finding is in contrast
to some previous studies. However, some of these studies were
performed in older people with major depression [16,18,19],
OH and WMH in Mild Dementia
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whereas in our study only a minority (17%) had clinically
significant depression (defined as a Montgomery Asberg De-
pression Rating Scale [40] score of at least 15). In the other studies
[15,17], a majority of the relevant subjects had DLB, known to
Table 1. Demographic and clinical characteristics.
Total sample
n=246
Volumetry group (n =82), vs. rest
of sample
Semi-quantitative group (n =139), vs.
rest of sample
Missing data
(out of n =246)
Age, median (IQR) 76.9 (71–81) 76.1 (70–81), p = 0.502 76.5 (71–81), p = 0.562 0
Women, n (%) 139 (57) 51 (62), p = 0.256 84 (60), p = 0.198 0
MMSE, median (IQR) 24 (22–26) 24 (22.5–26), p = 0.217 23.3 (22–25), p = 0.377 5
Coronary heart disease, n (%) 49 (21) 15 (19), p = 0.704 27 (21), p = 0.949 16
Hypertension (history of), n (%) 109 (46) 30 (38), p = 0.115 63 (47), p = 0.831 11
Diabetes mellitus, n (%) 21 (9) 9 (11), p = 0.495 10 (7), p = 0.455 12
APOEe4$1 allele, fractions (%) 93/153 (61) 31/53 (59), p = 0.803 61/98 (62), p = 0.748 93
Previous stroke, n (%) 33 (14) 8 (10), p = 0.302 18 (14), p = 0.960 14
Smoker (former/pres.), n (%) 111 (48) 37 (47), p = 0.862 62 (48), p = 0.949 16
Heart failure, n (%) 12 (5) 2 (3), p = 0.227 5 (4), p = 0.416 22
Orthostatic hypotension (present), n (%) 90 (46) 35 (47), p = 0.945 49 (44), p = 0.727 49
CIRS score, median (IQR) 6 (4–8) 6 (4–7), p = 0.402 6 (4–7), p = 0.780 10
No. of drugs, median (IQR) 4 (2–6) 4 (2–5), p = 0.159 4 (2–5), p = 0.466 11
Blood pressure lowering medication*, n (%) 141 (60) 41 (53), p = 0.167 77 (57), p = 0.361 9
Dementia categories p=0.000 p=0.002 0
Alzheimer’s disease, n (%) 138 (56) 60 (73) 89 (64)
DLB/PDD, n (%) 89 (36) 16 (20) 38 (27)
Vascular dementia, n (%) 11 (4) 2 (2) 5 (4)
FTD/alcoholic dem., n (%) 8 (3) 4 (5) 7 (5)
IQR = interquartile range; MMSE =Mini-Mental State Examination, normal range 24–30; AD=Alzheimer’s Disease; DLB =Dementia with Lewy Bodies; PDD=Parkinson’s
Disease Dementia; VaD= vascular dementia; FTD= Frontotemporal Dementia; CIRS = Cumulative Illness Rating Scale, range 0 (no impairment)-52 (extremely severe
impairment); APOE =Apolipoprotein E.
*antianginals, antihypertensives, tricyclic antidepressants, paroxetine,MAO inhibitors, dopamine agonists, diazepam, dipyridamole, phenothiazines, clozapine,
quetiapine, haloperidol.
Significant results are shown in bold typeface.
doi:10.1371/journal.pone.0052196.t001
Table 2. Demographic and clinical characteristics, lowest vs. highest WMH quartile.
Volumetry group Semi-quantitative group
OH (fractions) 10/17, 10/19 p= 0.970 12/25, 14/28 p= 1.000
Systolic BP drop (median)* 10, 10 p = 0.949 10, 17.5 p = 0.492
Diastolic BP drop (median)* 0, 0 p = 0.308 3, 0 p = 0.158
Standing syst. BP#110 (fractions) 1/17, 2/19 p = 1.000 4/26, 2/28 p = 0.413
Age (median)* 73, 79.5 p = 0.081 72, 78.4 p=0.002
Women (fractions) 15/20, 13/20 p= 0.730 19/37, 17/31 p= 0.966
AD (fractions) 16/20, 14/20 p= 0.715 22/37, 22/31 p= 0.463
Hypertension (fractions) 6/18, 11/20 p= 0.310 10/36, 16/31 p= 0.081
Coronary heart disease (fractions) 1/19, 5/20 p = 0.182 6/35, 7/30 p = 0.756
Diabetes mellitus (fractions) 1/19, 1/20 p = 1.000 3/36, 2/31 p = 1.000
APOEe4$1 allele (fractions) 11/12, 6/13 p=0.030 17/36, 10/21 p= 0.353
Previous stroke (fractions) 2/20, 4/19 p = 0.407 2/34, 9/28 p=0.016
Smoker (former or present)(fractions) 8/20, 11/20 p= 0.527 19/33, 16/30 p= 0.933
Heart failure (fractions) 0/20, 1/18 p = 0.474 2/34, 1/28 p = 1.000
WMH=white matter hyperintensities; OH= orthostatic hypotension; BP = blood pressure; AD=Alzheimer’s disease; APOE= apolipoprotein E.
*Mann-Whitney U-test, all other comparisons Chi-Square or Fisher’s Exact test.
Significant results are shown in bold typeface.
doi:10.1371/journal.pone.0052196.t002
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have lower standing systolic BP values than AD [23], whereas in
our study the majority had AD. Furthermore, in these two last
studies blood pressures were measured partly or only during
carotid sinus massage, as opposed to our study, in which the blood
pressures were measured only in the supine (or sitting) position and
during active standing. Subjects with OH according to these two
different methods may not be comparable, e.g. concerning the
pathophysiology of WMH.
In our study, the presence of at least one APOEe4 allele was
associated with reduced odds of having high WMH volume,
suggesting that other APOEe alleles (i.e. e2 and/or e3) may
increase the odds of high WMH volume. This hypothesis is
supported by at least two previous studies [41,42]. Notably, none
of these included subjects with dementia. Alternatively, patients
possessing the e4 allele may have more neurodegenerative changes
and thus develop dementia with a lower WMH load. However, the
majority of studies in this field have not demonstrated any
association between APOEe4 status and WMH burden [43–48].
In contrast to some previous studies (e.g. [49]), we did not find
any significant associations between hypertension and WMH. This
could have several possible explanations, including different
definitions of hypertension, different study designs, and differences
regarding samples.
This being a multicentre study, it is possible that the measured
or scored WMH values might vary systematically according to
scanning site. The results of the phantom studies, as well as the
results of the multivariate analyses including scanning site as
a variable, do not support this hypothesis.
The strengths of our study include the use of both quantitative
and semi-quantitative methods for evaluation of WMH severity.
Furthermore, we had data on a number of potential causal or risk
factors for WMH, enabling us to include these in the analyses.
Limitations include the cross-sectional design, the relatively
small sample size, and orthostatic BP measurements in a number
of cases obtained from the sitting, instead of the supine position. It
has previously been demonstrated that sit-stand testing for OH has
a very low diagnostic accuracy [50]. However, sit-stand measure-
ment only has been used in recent, similar studies [51,52]. In
addition, no standing BP measurements were made after 3
minutes. According to a previous study [53], at least 20–30% of
dementia patients have a delayed orthostatic response. Thus, our
methodology would tend to underestimate the prevalence of OH,
thereby possibly masking the potential association between OH
and WMH. Furthermore, the consensus definition of OH, which
was employed in the present study, does not in itself require the
orthostatic BP to be measured on more than one occasion. This is
a potential limitation, as this approach cannot distinguish those
having only transient OH from those having more persistent or
frequently recurring OH. The latter groups may have a higher risk
of being afflicted with the potential adverse consequences of BP
drops, such as syncope and cerebral hypoperfusion, and possibly
also the development of WMH. Ideally, in order to identify
individuals with more than transient OH, orthostatic blood
pressures should have been measured repeatedly over a period
of e.g. a few weeks. Moreover, if OH does play a role in the
development of WMH in mild dementia, it probably exerts its
effects over an extended period of time, also prior to the diagnosis
of dementia. Exploring this clearly would require a longitudinal
study. One final point is that due to missing data for some
variables, a relatively low number of subjects could be included in
the multiple logistic regression analyses, thus limiting the number
of predictors that could be entered into these analyses, as well as
their power.
Our results suggest that OH or low standing BP may not be
associated with WMH in older people with mild dementia, at least
not cross-sectionally. Instead, these changes may primarily be
associated with neurodegenerative disease [14], ageing [54],
hypertension and smoking [2,11], genetics [55], or combinations
of these factors. However, recent longitudinal studies indicate that
an unfavourable vascular risk factor status from midlife and
onwards may be of importance for the development of WMH in
later life [10,56,57]. Thus, the best opportunities for potential
prevention of these changes may lie in controlling established
vascular risk factors, starting no later than in midlife.
Conclusion
In a sample of older people with mild dementia, we found no
cross-sectional association between OH and WMH load. Future
studies should include larger samples, use a longitudinal design,
and use more rigorous BP measurement protocols.
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